Iris Ohyama's production of N95 masks in Japan

Iris Ohyama

Iris Ohyama is a Japanese maker of plastic consumer goods. It is Japan's leading producer for storage organizations. The company designs and produces items targeted at the markets of furniture, housewares, garden accessories, office products, and pet supplies.

After the pandemic of the coronavirus, these people in Japan need masks like other people. They not only need surgical masks but they need n95 masks as well. The government also collaborated with Iris Ohyama to manufacture n95 masks.

Iris Ohyama knows that n95 masks are the need of their health workers. Other than that, n95 masks are the best way to grow its market shares. So Iris Ohyama takes this thing as a responsibility and as a catching money way. Now Iris Ohyama is manufacturing millions and billions of masks (n95 masks) for Japan and other countries.

N95 masks

A disposable safety respirator device that can cover the mouth and nose is the N95 protective mask. It has a great philter media with 99 percent bacterial filtration efficiency that can be rated. It works by shielding you, like the much-feared NCOV 19, from breathing in toxic particles that can cause lung and body disease. It also works by holding tiny particles outside, such as dust, smoke.

When it comes to protecting you against air pollution and smog, the best of them is also fantastic. If you are living in a polluted environment, it is something precious. To filter airborne particles, such a system can function effectively, but it is pleasant to wear. It can provide a near and personalized fit and is designed to block at least 95% of particles from the 0.3-micron test.

Iris Ohyama production of N95 masks in Japan

Japan To fight the coronavirus pandemic, it needs 13 million N95 masks in the coming months. This month it can secure only 700,000.

Normally, the N95, which can block extremely tiny viral particles, is a disposable mask. But the health ministry has started calling for hospitals to reuse them as an emergency measure, with the shortage so severe.

Manufacturing companies keep this thing in mind that hospitals rely on whether products meet domestic and international standards in their purchasing decisions. For example, N95 masks must block at least 95% of particles that are 0.3 microns in diameter or more.

Outside the existing crisis, qualification might not be worth the time and effort. N95 masks are normally only used for a restricted range of conditions, such as intubation.

In view of the obstacles, “the decision to invest capital on making N95 masks is difficult for us to make”, said Iris Ohyama, a representative of the consumer goods group.

In a timely decision for medical staff who have been struggling with a shortage for months, a major Japanese consumer goods manufacturer will concentrate some of its production capacity on N95 face masks.

As early as next fall, Iris Ohyama plans to begin domestic production. Almost $10 million will be invested in renovating a factory in Miyagi Prefecture for this purpose. The facility will be able to manufacture 10,000 N95 masks and 1 million packets of antiseptic wipes a month.

Ohyama Akihiro, President of Iris Ohyama, said “domestic production is necessary in order to avoid competition with other countries to purchase masks on the international market”. The government says 70 percent of the N95 masks sold in Japan were made overseas before the pandemic.

Japan give subsidy to Iris Ohyama moving production out of China:

China being having two companies of Iris Ohyama take advantage to get more masks for its need then allow export. So consumer products manufacturer Iris Ohyama is set to become the first Japanese company to receive a government subsidy to shift production out of China.

Iris will start producing face masks at its Kakuda factory. In order to be independent of overseas suppliers, the company will produce masks from scratch, including nonwoven fabric. By August, it plans to manufacture 150 million masks a month.

Initially, Iris had intended to use a government subsidy to encourage the production of masks. The supply chain realignment subsidy will now also be requested. From the initial plan of 1 billion yen, total investment for the launch of mask production in Japan will increase to 3 billion yen, of which Iris expects to have subsidies covering approximately 75% of the new figure.

According to Iris Ohyama, we agreed to reinforce our production system because it is expected that the new coronavirus will take some time to stop, and long-term demand for n95 masks is expected, such as stockpiling by local governments.

Since April, when cases began to increase around the world, protective face wear has been in short supply. By offering subsidies to firms that make masks and other healthcare items, the government has been trying to ramp up domestic production.

In favor of investments to improve domestic development and procurement networks, Prime Minister Shinzo Abe has come out. Products that depend on one nation and have high added value will be returned as production bases to Japan, Abe said: “last month during a government meeting. Even if the products do not rely on one country and do not have high added value, ASEAN will diversify production”.

Prime Minister Shinzo Abe came out to make sure companies were prepared for the crisis. This to assure companies that the government is with them to give subsidies for support.

Featured products

Best Selling
3M 9205+ mask | N95 mask x 20 | NIOSH - Clinical Supplies USA3M 9205+ mask | N95 mask x 20 | NIOSH - Clinical Supplies USA
3M 9205+ mask | N95 mask x 20 | NIOSH 47 reviews
Sale price$149.95
Best Selling
3M 8511 mask | N95 mask x 10 | NIOSH - Clinical Supplies USA3M 8511 mask | N95 mask x 10 | NIOSH - Clinical Supplies USA
3M 8511 mask | N95 mask x 10 | NIOSH 205 reviews
Sale price$79.95
Best Selling
3M 8210 mask | N95 mask x 20 | NIOSH - Clinical Supplies USA3M 8210 mask | N95 mask x 20 | NIOSH - Clinical Supplies USA
3M 8210 mask | N95 mask x 20 | NIOSH 502 reviews
Sale price$159.95